本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Larimar Therapeutics, Inc.

3.92
+0.07001.82%
盤後3.940.0200+0.51%19:38 EDT
成交量:212.75萬
成交額:833.84萬
市值:4.08億
市盈率:-2.04
高:4.07
開:3.91
低:3.85
收:3.85
52周最高:6.42
52周最低:2.72
股本:1.04億
流通股本:5,754.16萬
量比:2.68
換手率:3.70%
股息:- -
股息率:- -
每股收益(TTM):-1.9258
每股收益(LYR):-2.2711
淨資產收益率:-139.63%
總資產收益率:-70.96%
市淨率:3.20
市盈率(LYR):-1.73

資料載入中...

2020/06/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/26

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/26

重要事件披露

8-K/A [Amend] - Current report
2020/06/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/08

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/08

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/03

重要事件披露

8-K - Current report
2020/06/02

重要事件披露

8-K - Current report
2020/05/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/04/27

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/24

重要事件披露

8-K - Current report
2020/04/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/09

重要事件披露

8-K - Current report
2020/03/05

重要事件披露

8-K - Current report
2020/03/05

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/03/05

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals